marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Bristol-Myers Squibb Company Balance Sheet 2011-2024 | BMY
Annual Balance Sheet Bristol-Myers Squibb Company
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
25.4 B | 26.1 B | 25.5 B | 35.4 B | 34.4 B | 438 M | 2.54 B | 2.47 B | 4.3 B | 2.26 B | 4.75 B | 5.74 B | -285 M |
Long Term Debt |
36.7 B | 35.1 B | 39.6 B | 48.3 B | 43.4 B | 5.65 B | 6.98 B | 5.72 B | 6.55 B | 7.24 B | 7.98 B | 6.57 B | 5.38 B |
Long Term Debt Current |
162 M | 136 M | 169 M | 2 B | 133 M | 1.25 B | - | 749 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 59.9 B | 10.2 B | 12.1 B | 8.52 B | 9.31 B | 10.3 B | 10.9 B | 14 B | 9.32 B |
Total Current Liabilities |
22.3 B | 21.9 B | 21.9 B | 19.1 B | 18.3 B | 10.7 B | 9.56 B | 8.84 B | 8.02 B | 8.46 B | 12.4 B | 8.28 B | 7.78 B |
Total Liabilities |
65.7 B | 65.7 B | 73.3 B | 80.6 B | 78.2 B | 20.9 B | 21.7 B | 17.4 B | 17.3 B | 18.8 B | 23.4 B | 22.3 B | 17.1 B |
Deferred Revenue |
- | - | - | - | 510 M | 172 M | 83 M | 762 M | 1 B | 1.17 B | 756 M | 825 M | 337 M |
Retained Earnings |
28.8 B | 25.5 B | 23.8 B | 21.3 B | 34.5 B | 34.1 B | 31.2 B | 33.5 B | 31.6 B | 32.5 B | 33 B | 32.7 B | 33.1 B |
Total Assets |
95.2 B | 96.8 B | 109 B | 118 B | 130 B | 35 B | 33.6 B | 33.7 B | 31.7 B | 33.7 B | 38.6 B | 35.9 B | 33 B |
Cash and Cash Equivalents |
11.5 B | 9.12 B | 14.3 B | 15 B | 12.3 B | 6.91 B | 5.42 B | 4.24 B | 2.38 B | 5.57 B | 3.59 B | 1.66 B | 5.78 B |
Book Value |
29.5 B | 31.1 B | 36 B | 37.9 B | 51.7 B | 14.1 B | 11.8 B | 16.3 B | 14.4 B | 15 B | 15.2 B | 13.6 B | 15.9 B |
Total Shareholders Equity |
29.4 B | 31.1 B | 35.9 B | 37.8 B | 51.6 B | 14 B | 11.7 B | 16.2 B | 14.3 B | 14.9 B | 15.2 B | 13.6 B | 16 B |
All numbers in USD currency
Quarterly Balance Sheet Bristol-Myers Squibb Company
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
48.7 B | 48.9 B | 49.5 B | 32.1 B | 34.7 B | 35.1 B | 35.1 B | 37 B | - | 37.4 B | 39.6 B | 39.7 B | 42.5 B | 44.5 B | 48.3 B | 48.3 B | 48.3 B | 48.3 B | 43.4 B | 43.4 B | 43.4 B | 43.4 B | 5.65 B | 5.65 B | 5.65 B | 5.65 B | 6.98 B | 6.98 B | 6.98 B | 6.98 B | 5.72 B | 5.72 B | 5.72 B | 5.72 B | 6.55 B | 6.55 B | 6.55 B | 6.55 B | 7.24 B | 7.24 B | 7.24 B | 7.24 B | 7.98 B | 7.98 B | 7.98 B | 7.98 B | 6.57 B | 6.57 B | 6.57 B | 6.57 B | 5.38 B | 5.38 B | 5.38 B | 5.38 B |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
76.5 B | 77.6 B | 82.5 B | 62.2 B | 61.5 B | 62.4 B | 65.7 B | 65.5 B | - | 71.4 B | 73.3 B | 73.6 B | 73.9 B | 74.8 B | 80.6 B | 80.6 B | 80.6 B | 80.6 B | 78.2 B | 78.2 B | 78.2 B | 78.2 B | 20.9 B | 20.9 B | 20.9 B | 20.9 B | 21.7 B | 21.7 B | 21.7 B | 21.7 B | 17.4 B | 17.4 B | 17.4 B | 17.4 B | 17.3 B | 17.3 B | 17.3 B | 17.3 B | 18.8 B | 18.8 B | 18.8 B | 18.8 B | 23.4 B | 23.4 B | 23.4 B | 23.4 B | 22.3 B | 22.3 B | 22.3 B | 22.3 B | 17.1 B | 17.1 B | 17.1 B | 17.1 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
16.1 B | 16.1 B | 15.6 B | 28.2 B | 27.4 B | 26.6 B | 25.5 B | 24.7 B | - | 23.9 B | 23.8 B | 22.6 B | 22.2 B | 22.2 B | 21.3 B | 21.3 B | 21.3 B | 21.3 B | 34.5 B | 34.5 B | 34.5 B | 34.5 B | 34.1 B | 34.1 B | 34.1 B | 34.1 B | 31.2 B | 31.2 B | 31.2 B | 31.2 B | 33.5 B | 33.5 B | 33.5 B | 33.5 B | 31.6 B | 31.6 B | 31.6 B | 31.6 B | 32.5 B | 32.5 B | 32.5 B | 32.5 B | 33 B | 33 B | 33 B | 33 B | 32.7 B | 32.7 B | 32.7 B | 32.7 B | 33.1 B | 33.1 B | 33.1 B | 33.1 B |
Total Assets |
93.7 B | 94.6 B | 99 B | 91.3 B | 93.5 B | 94.3 B | 96.8 B | 98.2 B | - | 103 B | 109 B | 111 B | 111 B | 112 B | 118 B | 118 B | 118 B | 118 B | 130 B | 130 B | 130 B | 130 B | 35 B | 35 B | 35 B | 35 B | 33.6 B | 33.6 B | 33.6 B | 33.6 B | 33.7 B | 33.7 B | 33.7 B | 33.7 B | 31.7 B | 31.7 B | 31.7 B | 31.7 B | 33.7 B | 33.7 B | 33.7 B | 33.7 B | 38.6 B | 38.6 B | 38.6 B | 38.6 B | 35.9 B | 35.9 B | 35.9 B | 35.9 B | 33 B | 33 B | 33 B | 33 B |
Cash and Cash Equivalents |
7.89 B | 6.29 B | 9.33 B | 7.57 B | 8.42 B | 9.05 B | 9.12 B | 7.96 B | 11 B | 12.6 B | 14 B | 13.9 B | 11 B | 11 B | 14.5 B | 14.5 B | 14.5 B | 14.5 B | 12.3 B | 12.3 B | 12.3 B | 12.3 B | 6.91 B | 6.91 B | 6.91 B | 6.91 B | 5.42 B | 5.42 B | 5.42 B | 5.42 B | 4.24 B | 4.24 B | 4.24 B | 4.24 B | 2.38 B | 2.38 B | 2.38 B | 2.38 B | 5.57 B | 5.57 B | 5.57 B | 5.57 B | 3.59 B | 3.59 B | 3.59 B | 3.59 B | 1.66 B | 1.66 B | 1.66 B | 1.66 B | 5.78 B | 5.78 B | 5.78 B | 5.78 B |
Book Value |
17.2 B | 17.1 B | 16.5 B | 29.1 B | 32 B | 31.9 B | 31.1 B | 32.7 B | - | 31.6 B | 36 B | 37.3 B | 36.9 B | 37.7 B | 37.9 B | 37.9 B | 37.9 B | 37.9 B | 51.7 B | 51.7 B | 51.7 B | 51.7 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 11.8 B | 11.8 B | 11.8 B | 11.8 B | 16.3 B | 16.3 B | 16.3 B | 16.3 B | 14.4 B | 14.4 B | 14.4 B | 14.4 B | 15 B | 15 B | 15 B | 15 B | 15.2 B | 15.2 B | 15.2 B | 15.2 B | 13.6 B | 13.6 B | 13.6 B | 13.6 B | 15.9 B | 15.9 B | 15.9 B | 15.9 B |
Total Shareholders Equity |
17.1 B | 17 B | 16.5 B | 29 B | 32 B | 31.8 B | 31.1 B | 32.7 B | - | 31.6 B | 35.9 B | 37.2 B | 36.8 B | 37.6 B | 37.8 B | 37.8 B | 37.8 B | 37.8 B | 51.6 B | 51.6 B | 51.6 B | 51.6 B | 14 B | 14 B | 14 B | 14 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 14.3 B | 14.3 B | 14.3 B | 14.3 B | 14.9 B | 14.9 B | 14.9 B | 14.9 B | 15.2 B | 15.2 B | 15.2 B | 15.2 B | 13.6 B | 13.6 B | 13.6 B | 13.6 B | 16 B | 16 B | 16 B | 16 B |
All numbers in USD currency